Patent · US Active

Nucleic acid probes and methods for detecting clinically important fungal pathogens

US7741461B2 · kind B2 · utility

2Cited by

15References

9Claims

0Family size

Assignees

Innogenetics N.V. · BE
Enterprise Ireland · IE
National University of Ireland, Galway · IE

Inventors

Terry James Smith · Galway, IE
Majella Maher · Moycullen, IE
Cara Martin · Dublin, IE
Geert Jannes · Kessel-Lo, BE
Rudi Rossau · Ekeren, BE
Marjo Van der Weide · Terneuzen, NL

Key dates

Filing date	Oct 19, 2004
Grant date	Jun 22, 2010
Priority date	—
Expiry date	Jun 16, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/6895
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The current invention relates to the field of detection and identification of clinically important fungi. More particularly, the present invention relates to species specific probes originating from the Internal Transcribed Spacer (ITS) region of rDNA for the detection of fungal species such as Candida albicans, Candida parapsilosis, Candida tropicalis, Candida kefyr, Candida krusei, Candida glabrata, Candida dubliniensis, Aspergillus flavus, Aspergillus versicolor, Aspergillus nidulans, Aspergillus fumigatus, Cryptococcus neoformans and Pneumocystis carinii in clinical samples, and methods using said probes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.